HLS vs PAR

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

HLS

HEALIUS FPO [HLS]

49LOW

PAR

PARA BIO FPO [PAR]

49LOW

Score Breakdown

HLS PAR
Technical
57
68
Catalyst
61
67
Sentiment
50
50
Fundamental
91
48
Momentum
34
52
Risk Gate
32
50

Key Metrics

HLS Metric PAR
$400.8MMarket Cap$113.5M
3.6MAvg Volume (20d)910K
+6.2%Short Interest+0.4%
$1.63552-Week High$0.480
$0.54552-Week Low$0.240
+5.0%Daily Change+2.8%
$0.567Entry Price$0.257
-69.3%ROE-180.2%
-12.3%Profit MarginN/A

Active Signals

HLS Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.3x)
●EPS estimates revised upward (+10pts)

PAR Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Very high P/S ratio (13426.2x)
●Strong revenue growth (+51%)

Ask Scout AI to compare HLS and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
HLS Full Analysis → PAR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).